Asoprisnil in endometriosis

Phase 2, open-label, single-arm trial of asoprisnil in endometriosis, sponsored by Abbott Laboratories. Primary endpoints: Change from baseline in pelvic pain and dysmenorrhea assessed by visual analog scale at 12 months and Change from baseline in pelvic pain, dysmenorrhea, dyspareunia, pelvic tenderness and induration assessed by modified Biberoglu and Behrman grading scale at 12 months. Started Dec 2002; status: completed.